(Q44123449)

30 November 2017

title

Lactose modifications enhance its drug performance in the novel multiple dose Taifun DPI. (English)

1 reference

30 November 2017

7

Kristiina Järvinen

1 reference

30 November 2017

Päivi Harjunen

1

1 reference

30 November 2017

Vesa-Pekka Lehto

2

1 reference

30 November 2017

Krista Martimo

3

1 reference

30 November 2017

Eero Suihko

4

1 reference

30 November 2017

Tapio Lankinen

5

1 reference

30 November 2017

Petteri Paronen

6

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

European Journal of Pharmaceutical Sciences

30 November 2017

published in

1 reference

30 November 2017

volume

16

1 reference

30 November 2017

issue

4-5

1 reference

30 November 2017

page(s)

313-321

1 reference

Evaluation of flow properties of dry powder inhalation of salbutamol sulfate with lactose carrier

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900126-4

7 January 2021

Pulmonary deposition of lactose carriers used in inhalation powders

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900126-4

7 January 2021

The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900126-4

7 January 2021

Influence of the moisture on the performance of a new dry powder inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900126-4

7 January 2021

Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900126-4

7 January 2021

Pulmonary drug delivery from the Taifun dry powder inhaler is relatively independent of the patient's inspiratory effort

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900126-4

7 January 2021

Review of dry powder inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900126-4

7 January 2021

The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900126-4

7 January 2021

The effects of carrier size and morphology on the dispersion of salbutamol sulphate after aerosolization at different flow rates

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900126-4

7 January 2021

The influence of carrier morphology on drug delivery by dry powder inhalers.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900126-4

7 January 2021

Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900126-4

7 January 2021

Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900126-4

7 January 2021

10.1016/S0928-0987(02)00126-4

Identifiers

DOI

1 reference

30 November 2017

1 reference